News
VIRI
0.3570
+8.28%
0.0273
Weekly Report: what happened at VIRI last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at VIRI last week (0212-0216)?
Weekly Report · 02/19 12:15
12 Health Care Stocks Moving In Monday's Pre-Market Session
SeaStar Medical Holding (NASDAQ:ICU) shares rose 27.9% to $1.1 during Monday's pre-market session. Aesthetic Medical Intl shares increased by 20.39% and Virios Therapeutics stock rose 19.25% in the same session. Losers AN2 Therapeutic and Invivyd stock declined by 69.0% during the session.
Benzinga · 02/12 13:05
Weekly Report: what happened at VIRI last week (0205-0209)?
Weekly Report · 02/12 12:01
Weekly Report: what happened at VIRI last week (0129-0202)?
Weekly Report · 02/05 12:13
Weekly Report: what happened at VIRI last week (0122-0126)?
Weekly Report · 01/29 11:57
Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge
U.S. Stocks traded higher toward the end of trading on Monday, with the Dow Jones index gaining more than 100 points. The Dow traded up 0.27% to 37,967.81 while the NASDAQ rose 0.31%. Archer-Daniels-Midland Company placed its CFO on leave and updated its FY23 outlook. Sagimet Biosciences Inc. Shares shot up 105% to $13.97 on Monday.
Benzinga · 01/22 19:19
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of CommScope Holding Company, Inc. (NASDAQ:COMM) fell sharply during Monday's mid-day session. Sagimet Biosciences Inc. Shares jumped 135% to $15.99. Rail Vision Ltd. Shares surged 54.5% in the same session.
Benzinga · 01/22 18:08
Virios Therapeutics Inc: Other preliminary proxy statements
Press release · 01/22 18:04
12 Health Care Stocks Moving In Monday's Intraday Session
Sagimet Biosciences (NASDAQ:SGMT) stock rose 103.5% to $13.88 during Monday's regular session. The company's market cap stands at $317.8 million. Bullfrog AI Hldgs shares moved upwards by 41.1% during the session.
Benzinga · 01/22 17:31
Crude Oil Surges Over 2%; US Leading Economic Index Falls In December
U.S. Stocks traded higher midway through trading on Monday, with the Dow Jones index gaining 150 points. The Dow traded up 0.41% to 38,018.23 while the NASDAQ rose 0.30%. Real estate shares rose by 0.7% on Monday while consumer discretionary shares fell 0.5%. US leading economic index falls 0.1% for December. Sagimet Biosciences Inc. Shares shot up 94% and Rail Vision Ltd. Shares surged 69% in trading.
Benzinga · 01/22 17:18
US Stocks Higher; Nasdaq Jumps 100 Points
U.S. Stocks traded higher on Monday, with the Nasdaq Composite gaining around 100 points. The Dow traded up 0.55% and the NASDAQ rose 0.71%. Real estate shares rose by 1.4% on Monday while consumer staples shares fell by 0.2%. US leading index fell 0.1% for December, versus analysts' expectations for a decline.
Benzinga · 01/22 15:15
Weekly Report: what happened at VIRI last week (0115-0119)?
Weekly Report · 01/22 12:02
Weekly Report: what happened at VIRI last week (0108-0112)?
Weekly Report · 01/15 11:57
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
JetBlue Airways Corporation shares dipped 10.9% to $5.13 on Tuesday. NexImmune, Inc. Shares jumped 89.2% in Tuesday's mid-day session. The company reported better-than-expected quarterly results. Other stocks in the news include Illumina and Urban Outfitters. Denali Capital Acquisition Corp. Shares fell 28.6%.
Benzinga · 01/09 18:00
Weekly Report: what happened at VIRI last week (0101-0105)?
Weekly Report · 01/08 12:03
Virios Therapeutics Inc: Current report
Press release · 01/03 14:18
Weekly Report: what happened at VIRI last week (1225-1229)?
Weekly Report · 01/01 11:55
Weekly Report: what happened at VIRI last week (1218-1222)?
Weekly Report · 12/25/2023 12:11
Weekly Report: what happened at VIRI last week (1211-1215)?
Weekly Report · 12/18/2023 12:19
More
Webull provides a variety of real-time VIRI stock news. You can receive the latest news about Virios Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VIRI
Virios Therapeutics, Inc. is a development-stage biotechnology company. The Company is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia (FM) and Long-COVID (LC). Its lead candidate, IMC-1, is a novel, proprietary, fixed dose combination of famciclovir and celecoxib. IMC-1 represents a novel combination, dual mechanism antiviral therapy designed to synergistically suppress herpes virus activation and replication, with the end goal of reducing viral mediated disease burden. IMC-2 is a combination of valacyclovir and celecoxib that is believed to have specific activity against Epstein-Barr virus (herpesvirus HHV-4), as well as other herpesviruses. IMC-1 and IMC-2 combine two specific mechanisms of action purposely designed to inhibit herpesvirus activation and replication, thereby converting activated herpesvirus back to dormancy and/or by keeping the herpesvirus in a latent or dormant state.